The Food and Drug Administration has not evaluated these statements. This product is not designed to diagnose, treat, cure, or prevent any medical condition. Not intended for human consumption.
CJC-1295 and Ipamorelin combinations are studied in laboratory research for their interaction with growth hormone–associated receptor signaling networks and peptide-mediated endocrine regulatory mechanisms.